Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010
by Translational Oncology Research International.
Recruitment status was Active, not recruiting
Study NCT00591123 Information provided by Translational Oncology Research International
First Received on December 28, 2007. Last Updated on July 26, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Adenocarcinoma
Adenocarcinoma, Mucinous
Esophageal Neoplasms
More general conditions related to this trial
Carcinoma
Digestive System Diseases
Digestive System Neoplasms
Esophageal Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Head and Neck Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Cystic, Mucinous, and Serous
Neoplasms, Glandular and Epithelial
Interventions listed in this trial
FOLFOX and Erlotinib
Additional drug interventions recognized in this trial
Erlotinib
Leucovorin
Levoleucovorin
Oxaliplatin
More general drug interventions related to this trial
Antidotes
Antineoplastic Agents
Enzyme Inhibitors
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Protein Kinase Inhibitors
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Translational Oncology Research International
University of California, Los Angeles
Sanofi
OSI Pharmaceuticals
Back to top of Main Content
